Tylenol Extra Strengthacetaminophen

According to the FDA label: Uses temporarily relieves minor aches and pains due to: the common cold headache backache minor pain of arthritis toothache muscular aches premenstrual and menstrual cramps temporarily reduces fever

410,216 adverse event reports submitted to the FDA (1998–2026)

This data reflects voluntary reports submitted to the FDA's Adverse Event Monitoring System (AEMS), formerly the FDA Adverse Event Reporting System (FAERS). A report does not mean the medication caused the event. Data may be incomplete or contain errors. Learn more about AEMS. New to this data? Read our guide on how to interpret FDA adverse event reports →
New to FDA adverse event data? Here's how to read these reports →

Top Reported Adverse Events

The most frequently reported events in association with Tylenol Extra Strength in the FAERS database. These are events reported by patients taking this medication, not necessarily caused by it. A single report may include multiple events.

Show these terms with plain-language definitions

Tap any term below for a plain-language definition.

Browse the full glossary →

Ranked by frequency of reports, not severity. The most-reported event is not necessarily the most dangerous or the most common in patients taking this drug.

Who Is Reporting

Demographics of patients in FAERS reports that included this information. Not all reports include patient demographics.

By Sex

View reporter sex data as a table
Tylenol Extra Strength adverse event reports by reporter sex
SexReports
Female233,390
Male126,742
Unknown660

By Age Group

View age group data as a table
Tylenol Extra Strength adverse event reports by reporter age group
Age groupReports
0-1718,065
18-3429,002
35-4945,077
50-6469,580
65-7453,740
75+53,541

This shows who filed reports, reflecting who takes this drug and who tends to report, not who is at greatest risk.

Reported Outcomes

Outcomes recorded in FAERS reports that included Tylenol Extra Strength. A single report may involve multiple reactions, each with a different outcome. These categories are defined by FDA reporting guidelines, not by PillSignal.

View outcome data as a table
Tylenol Extra Strength adverse event reports by reported outcome
OutcomeReports
Other Serious193,037
Hospitalization150,721
Non-Serious104,464
Death60,249
Life-Threatening24,539
Disability15,065

Serious outcomes are far more likely to be reported than mild ones, so this overstates how often outcomes are serious. A recorded death does not mean the drug caused it.

Number of FAERS reports received per quarter for Tylenol Extra Strength. Changes in volume may reflect shifts in prescribing rates, media attention, or reporting behavior, not changes in the medication's safety profile.

View report trend as a table
Tylenol Extra Strength adverse event reports by year
YearReports
19981
19995
20012
20022
20036
20043,849
20053,752
20063,985
20073,601
20084,604
20093,928
20105,109
20118,621
201211,117
20137,326
20148,985
201516,489
201619,531
201719,119
201822,310
201927,011
202033,096
202134,063
202239,292
202339,736
202440,646
202544,072
2026 (partial)9,958

The steep increase around 2004 reflects the FDA's move to electronic submission, not a change in this drug's safety. Trends track reporting volume, not risk.

Medications commonly reported with Tylenol Extra Strength

In FDA adverse event reports that mention Tylenol Extra Strength, these medications appeared most often in the same report.

This reflects co-occurrence in submitted reports, not evidence of drug interaction or combined risk. People often report several medications taken for the same condition or for unrelated reasons. Talk to a doctor or pharmacist about your specific medications.

Other medications with similar adverse event profiles in FDA FAERS reports.

Data Source

This data is sourced from the FDA's Adverse Event Monitoring System (AEMS), formerly FAERS, via the OpenFDA API. PillSignal is not affiliated with the FDA.

View this data on the FDA website →

Data last updated: June 2026